|
SSH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.038400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.628400E-01 |
| Normal-vs-Stage2 |
1.368170E-01 |
| Normal-vs-Stage3 |
2.313600E-01 |
| Normal-vs-Stage4 |
2.960400E-01 |
| Stage1-vs-Stage2 |
7.410200E-02 |
| Stage1-vs-Stage3 |
9.981700E-02 |
| Stage1-vs-Stage4 |
1.499610E-01 |
| Stage2-vs-Stage3 |
5.851600E-01 |
| Stage2-vs-Stage4 |
6.676400E-01 |
| Stage3-vs-Stage4 |
9.598200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.238600E-01 |
| Normal-vs-AfricanAmerican |
6.410600E-01 |
| Normal-vs-Asian |
2.174400E-01 |
| Caucasian-vs-AfricanAmerican |
9.862000E-01 |
| Caucasian-vs-Asian |
3.181900E-02 |
| AfricanAmerican-vs-Asian |
8.638300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.723000E-01 |
| Normal-vs-Female |
6.651000E-01 |
| Male-vs-Female |
7.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.149400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.779200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.474200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.518400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.601200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.715400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.942390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.193620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.110300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.533800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.295700E-02 |
| Normal-vs-Grade 2 |
8.228200E-01 |
| Normal-vs-Grade 3 |
1.142020E-01 |
| Normal-vs-Grade 4 |
5.675000E-01 |
| Grade 1-vs-Grade 2 |
5.164400E-02 |
| Grade 1-vs-Grade 3 |
1.784400E-02 |
| Grade 1-vs-Grade 4 |
2.657900E-02 |
| Grade 2-vs-Grade 3 |
3.748000E-02 |
| Grade 2-vs-Grade 4 |
4.202000E-01 |
| Grade 3-vs-Grade 4 |
5.778600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.331200E-01 |
| Normal-vs-ccB subtype |
9.747400E-01 |
| ccA subtype-vs-ccB subtype |
5.821000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.766400E-01 |
| Normal-vs-N1 |
5.335400E-01 |
| N0-vs-N1 |
4.099200E-01 |
|
|
